Muscular dystrophies involving the dystrophin–glycoprotein complex: an overview of current mouse models

Campbell, 1995, Molecular basis of three muscular dystrophies: disruption of the cytoskeleton-extracellular matrix linkage, Cell, 80, 675, 10.1016/0092-8674(95)90344-5 Straub, 1997, Muscular dystrophies and the dystrophin-glycoprotein complex, Curr Opin Neurol, 10, 168, 10.1097/00019052-199704000-00016 Lim, 1998, The sarcoglycan complex in limb-girdle muscular dystrophy, Curr Opin Neurol, 11, 443, 10.1097/00019052-199810000-00006 Bushby, 1999, The limb-girdle muscular dystrophies-multiple genes, multiple mechanisms, Hum Mol Gen, 8, 1875, 10.1093/hmg/8.10.1875 Cohn, 2000, The molecular basis of muscular dystrophies, Muscle Nerve, 23, 1456, 10.1002/1097-4598(200010)23:10<1456::AID-MUS2>3.0.CO;2-T Hoffman, 1987, Dystrophin: the protein product of the Duchenne muscular dystrophy locus, Cell, 51, 919, 10.1016/0092-8674(87)90579-4 Campbell, 1989, Association of dystrophin and an integral membrane glycoprotein, Nature, 338, 259, 10.1038/338259a0 Ervasti, 1990, Deficiency of a glycoprotein component of the dystrophin complex in dystrophic muscle, Nature, 345, 315, 10.1038/345315a0 Yoshida, 1990, Glycoprotein complex anchoring dystrophin to sarcolemma, J Biochem, 108, 748, 10.1093/oxfordjournals.jbchem.a123276 Ibraghimov-Beskrovnaya, 1992, Primary structure of dystrophin-associated glycoproteins linking dystrophin to the extracellular matrix, Nature, 355, 696, 10.1038/355696a0 Roberds, 1994, Missense mutations in the adhalin gene linked to autosomal recessive muscular dystrophy, Cell, 78, 625, 10.1016/0092-8674(94)90527-4 Adams, 1993, Two isoforms of mouse syntrophin, a 58 kd dystrophin-associated protein, differ in primary structure and tissue distribution, Neuron, 11, 531, 10.1016/0896-6273(93)90157-M Yang, 1995, Identification of alpha-syntrophin binding to the syntrophin triplet, dystrophin and utrophin, J Biol Chem, 270, 4975, 10.1074/jbc.270.10.4975 Lim, 1995, Beta-sarcoglycan: characterization and role in limb-girdle muscular dystrophy linked to 4q12, Nat Genet, 11, 257, 10.1038/ng1195-257 Bönnemann, 1995, Beta-sarcoglycan (A3b) mutations cause autosomal recessive muscular dystrophy with loss of the sarcoglycan complex, Nat Genet, 11, 266, 10.1038/ng1195-266 Noguchi, 1995, Mutations in the dystrophin-associated protein γ-sarcoglycan in chromosome 13 muscular dystrophy, Science, 270, 819, 10.1126/science.270.5237.819 Nigro, 1996, Autosomal recessive limb-girdle muscular dystrophy, LGMD2F, is caused by a mutation in the δ-sarcoglycan gene, Nat Genet, 14, 195, 10.1038/ng1096-195 Jung, 1996, Characterization of δ-sarcoglycan, a novel component of the oligomeric sarcoglycan complex involved in limb-girdle muscular dystrophy, J Biol Chem, 271, 32321, 10.1074/jbc.271.50.32321 Crosbie, 1997, Sarcospan, the 25 kDa transmembrane component of the dystrophin-glycoprotein complex, J Biol Chem, 272, 31221, 10.1074/jbc.272.50.31221 Piluso, 2000, γ1- and γ2-syntrophins, two novel dystrophin binding proteins localized in neuronal cells, J Biol Chem, 275, 15851, 10.1074/jbc.M000439200 Grady, 1999, Role for the α-dystrobrevin in the pathogenesis of dystrophin dependent muscular dystrophies, Nat Cell Biol, 4, 215, 10.1038/12034 Ervasti, 1991, Membrane organization of the dystrophin-glycoprotein complex, Cell, 66, 1121, 10.1016/0092-8674(91)90035-W Ervasti, 1993, A role for dystrophin-glycoprotein complex as a transmembrane linker between laminin and actin, J Cell Biol, 122, 809, 10.1083/jcb.122.4.809 Sunada, 1994, Deficiency of merosin in dystrophic dy mice and genetic linkage of laminin M chain to dy locus, J Biol Chem, 269, 13729, 10.1016/S0021-9258(17)36704-2 Campanelli, 1994, A role for dystrophin associated glycoproteins and utrophin in agrin-induced AChR clustering, Cell, 77, 663, 10.1016/0092-8674(94)90051-5 Gee, 1994, Dystroglycan-α, a dystrophin-associated glycoprotein, is a functional agrin receptor, Cell, 77, 675, 10.1016/0092-8674(94)90052-3 Talts, 1999, Binding of the G domains of laminin α1 and α2 chains and perlecan to heparin, sulfatides, α-dystroglycan and several extracellular matrix proteins, EMBO J, 18, 863, 10.1093/emboj/18.4.863 Bowe, 2000, The small leucine-rich repeat proteoglycan biglycan binds to α-dystroglycan and is upregulated in dystrophic muscle, J Cell Biol, 146, 801, 10.1083/jcb.148.4.801 Sugita, 2001, A stochiometric complex of neurexins and dystroglycan in brain, J Cell Biol, 154, 435, 10.1083/jcb.200105003 Weller, 1990, Dystrophin-deficient mdx muscle fibers are preferentially vulnerable to necrosis induced by experimental lengthening contractions, J Neurol Sci, 100, 9, 10.1016/0022-510X(90)90005-8 Petrof, 1993, Dystrophin protects the sarcolemma from stresses developed during muscle contraction, Proc Natl Acad Sci USA, 90, 3710, 10.1073/pnas.90.8.3710 Piccolo, 1995, Primary adhalinopathy: a common cause of autosomal recessive muscular dystrophy of variable severity, Nat Genet, 10, 243, 10.1038/ng0695-243 Allamand, 1997, Mild congenital muscular dystrophy in two patients with an internally deleted laminin alpha2-chain, Hum Mol Genet, 6, 747, 10.1093/hmg/6.5.747 Yang, 1995, SH3 domain mediated interaction of dystroglycan and Grb2, J Biol Chem, 270, 11711, 10.1074/jbc.270.20.11711 Thompson, 2000, Filamin 2 (FLN2): a muscle-specific sarcoglycan interacting protein, J Cell Biol, 148, 115, 10.1083/jcb.148.1.115 Ahn, 1996, The three human syntrophin genes are expressed in diverse tissues, have distinct chromosomal locations, and each bind to dystrophin and its relatives, J Biol Chem, 271, 2724, 10.1074/jbc.271.5.2724 Peters, 1997, Differential association of syntrophin pairs with the dystrophin complex, J Cell Biol, 138, 81, 10.1083/jcb.138.1.81 Brenman, 1996, Interaction with nitric oxide synthase with the postsynaptic density protein PSD-95 and α1-syntrophin mediated by PZD domains, Cell, 84, 757, 10.1016/S0092-8674(00)81053-3 Schultz, 1998, Specific interactions between the syntrophin PDZ domain and the voltage-gated sodium channels, Nature Struct Biol, 5, 19, 10.1038/nsb0198-19 Gee, 1998, Interaction of brain and muscle sodium channels with multiple members of the syntrophin family of dystrophin-associated proteins, J Neurosci, 18, 128, 10.1523/JNEUROSCI.18-01-00128.1998 Lumeng, 1999, Interactions between β2-syntrophin and family of microtubule-associated serine/threonine kinases, Nat Neurosci, 2, 611, 10.1038/10165 Wagner, 1993, The 87K postsynaptic membrane protein from Torpedo is a protein-tyrosine kinase substrate homologous to dystrophin, Neuron, 10, 511, 10.1016/0896-6273(93)90338-R Sadoulet-Puccio, 1997, Dystrobrevin and dystrophin: an interaction through coiled-coil motifs, Proc Natl Acad Sci USA, 94, 12413, 10.1073/pnas.94.23.12413 Yoshida, 2000, Biochemical evidence for association of dystrobrevin with the sarcoglycan-sarcospan complex as a basis for understanding sarcoglycanopathies, Hum Mol Genet, 9, 1033, 10.1093/hmg/9.7.1033 Roberts, 1998, Dystrophins in vertebrates and invertebrates, Hum Mol Gen, 79, 589, 10.1093/hmg/7.4.589 Greener, 2000, Conservation of components of the dystrophin complex in Drosophila, FEBS Lett, 482, 13, 10.1016/S0014-5793(00)02018-4 Hutter, 2000, Conservation and novelty in the evolution of cell adhesion and extracellular matrix genes, Science, 287, 989, 10.1126/science.287.5455.989 Sicinski, 1989, The molecular basis of muscular dystrophy in the mdx mouse: a point mutation, Science, 244, 1578, 10.1126/science.2662404 Ohlendieck, 1991, Dystrophin-associated proteins are greatly reduced in skeletal muscle from mdx mice, J Cell Biol, 115, 1685, 10.1083/jcb.115.6.1685 Bulfield, 1984, Skeletal muscle pathology in X chromosome-linked muscular dystrophy (mdx) in the mouse, Proc Natl Acad Sci USA, 81, 1189, 10.1073/pnas.81.4.1189 Stedman, 1991, The mdx diaphragm reproduces the degenerative changes of Duchenne muscular dystrophy, Nature, 352, 536, 10.1038/352536a0 Stevens, 2000, The capacity of mdx mouse diaphragm muscle to do oscillatory work, J Physiol, 1, 457, 10.1111/j.1469-7793.2000.t01-3-00457.x Megeney, 1996, MyoD is required for myogenic stem cell function in adult skeletal muscle, Genes Dev, 10, 1173, 10.1101/gad.10.10.1173 Garry, 2000, Myogenic stem cell function is impaired in mice lacking the forkhead/winged helix protein MNF, Proc Natl Acad Sci USA, 97, 5416, 10.1073/pnas.100501197 Deckoninck, 1997, Utrophin-dystrophin-deficient mice as a model for Duchenne Muscular Dystrophy, Cell, 90, 7171 Grady, 1997, Skeletal and cardiac myopathies in mice lacking utrophin and dystrophin: a model for Duchenne muscular dystrophy, Cell, 90, 729, 10.1016/S0092-8674(00)80533-4 Rafael, 1998, Skeletal muscle-specific expression of a utrophin transgene rescues utrophin-dystrophin deficient mice, Nat Genet, 19, 79, 10.1038/ng0598-79 Duclos, 1998, Progressive muscular dystrophy in α-sarcoglycan deficient mice, J Cell Biol, 142, 1461, 10.1083/jcb.142.6.1461 Byers, 1993, An alternative dystrophin transcript specific to peripheral nerve, Nat Genet, 4, 87, 10.1038/ng0593-77 Schofield, 1994, Apo-dystrophin-1 and apo-dystrophin-2, products of the Duchenne muscular dystrophy locus: expression during mouse embryogenesis and in cultured cell lines, Hum Mol Genet, 8, 1309 D'Souza, 1995, A novel dystrophin isoforms is required for normal retinal electrophysiology, Hum Mol Genet, 4, 837, 10.1093/hmg/4.5.837 Lidov, 1995, Dp140: a novel 140 kDa CNS transcript from the dystrophin locus, Hum Mol Genet, 3, 329, 10.1093/hmg/4.3.329 Durbeej, 1997, Transient expression of Dp140, a product of the Duchenne muscular dystrophy locus, during kidney tubulogenesis, Dev Biol, 181, 156, 10.1006/dbio.1996.8430 Sarig, 1999, Targeted inactivation of Dp71, the major non-muscle product of the DMD gene: differential activity of the Dp71 promoter during development, Hum Mol Genet, 8, 1, 10.1093/hmg/8.1.1 Im, 1996, Differential expression of dystrophin isoforms in strains of mdx mice with different mutations, Hum Mol Genet, 8, 1149, 10.1093/hmg/5.8.1149 Rafael, 1999, Dystrophin and utrophin do not play crucial roles in nonmuscle tissues in mice, Muscle Nerve, 22, 517, 10.1002/(SICI)1097-4598(199904)22:4<517::AID-MUS14>3.0.CO;2-6 Araki, 1997, Targeted disruption of exon 52 in the mouse dystrophin gene induced muscle degeneration similar to that observed in Duchenne muscular dystrophy, Biochem Biophys Res Com, 238, 492, 10.1006/bbrc.1997.7328 Kameya, 1999, α1-syntrophin gene disruption results in the absence of neuronal-type nitric-oxide synthase at the sarcolemma but does not induce muscle degeneration, J Biol Chem, 274, 2193, 10.1074/jbc.274.4.2193 Adams, 2000, Absence of α-syntrophin leads to structurally aberrant neuromuscular synapses deficient in utrophin, J Cell Biol, 150, 1385, 10.1083/jcb.150.6.1385 Yokota, 2000, Aquaporin-4 is absent at the sarcolemma and at perivascular astrocyte endfeet in α1-syntrophin knockout mice, Proc Japan Acad, 76, 22, 10.2183/pjab.76.22 Liu, 1999, Immunocytochemical studies of aquaporin-4 in the skeletal muscle, J Neurol Sci, 15, 24, 10.1016/S0022-510X(99)00051-9 Yang, 2000, Skeletal muscle function and water permeability in aquaporin-4 deficient mice, Am J Physiol Cell Physiol, 278, 1105, 10.1152/ajpcell.2000.278.6.C1108 Huang, 1993, Targeted disruption of the nitric oxide synthase gene, Cell, 75, 1273, 10.1016/0092-8674(93)90615-W Crosbie, 1998, mdx muscle pathology is independent of nNOS perturbation, Hum Mol Genet, 7, 823, 10.1093/hmg/7.5.823 Sander, 2000, Functional muscle ischemia in neuronal nitric oxide synthase deficient skeletal muscle of children with Duchenne muscular dystrophy, Proc Natl Acad Sci USA, 5, 13818, 10.1073/pnas.250379497 Minetti, 1998, Mutations in the caveolin-3 gene cause autosomal dominant limb-girdle muscular dystrophy, Nat Genet, 18, 365, 10.1038/ng0498-365 Song, 1996, Expression of caveolin-3 in skeletal, cardiac, and smooth muscle cells: caveolin-3 is a component of the sarcolemma and co-fractionates with dystrophin and dystrophin-associated proteins, J Biol Chem, 271, 15160, 10.1074/jbc.271.25.15160 Crosbie, 1998, Caveolin-3 is not an integral component of the dystrophin–glycoprotein complex, FEBS Lett, 427, 279, 10.1016/S0014-5793(98)00442-6 Hagiwara, 2000, Caveolin-3 deficiency causes muscle degeneration in mice, Hum Mol Genet, 9, 3047, 10.1093/hmg/9.20.3047 Galbiati, 2001, Caveolin-3 null mice show a loss of caveolae, changes in the microdomain distribution of the dystrophin–glycoprotein complex, and T-tubule abnormalities, J Biol Chem, 276, 21425, 10.1074/jbc.M100828200 Durbeej, 1999, Biochemical characterization of the epithelial dystroglycan complex, J Biol Chem, 274, 26609, 10.1074/jbc.274.37.26609 Durbeej, 1995, Non-muscle α-dystroglycan is involved in epithelial development, J Cell Biol, 130, 79, 10.1083/jcb.130.1.79 Durbeej, 1998, Distribution of dystroglycan in normal adult mouse tissues, J Histochem Cytochem, 46, 449, 10.1177/002215549804600404 Henry, 1998, A role for dystroglycan in basement membrane assembly, Cell, 95, 859, 10.1016/S0092-8674(00)81708-0 Williamson, 1997, Dystroglycan is essential for early embryonic development: disruption of Reichert's membrane in Dag1-null mice, Hum Mol Genet, 6, 831, 10.1093/hmg/6.6.831 Côté, 1999, Chimeric mice deficient in dystroglycans develop muscular dystrophy and have disrupted monaural synapses, Nat Genet, 23, 338, 10.1038/15519 Grewal, 2001, Mutant glycosyltransferase and altered glycosylation of α-dystroglycan in the myodystrophy mouse, Nat Genet, 28, 151, 10.1038/88865 Yoshida, 2001, Muscular dystrophy and neuronal migration disorder caused by mutations in a glycosyltransferase, POMGnT1, Dev Cell, 1, 717, 10.1016/S1534-5807(01)00070-3 Kano, 2002, Deficiency of α-dystroglycan in muscle-eye-brain disease, Biochem Biophys Res Comm, 291, 1283, 10.1006/bbrc.2002.6608 Hayashi, 2001, Selective deficiency of alpha-dystroglycan in Fukuyama-type congenital muscular dystrophy, Neurology, 10, 115, 10.1212/WNL.57.1.115 Tomé, 1998, The Peter Emil Becker Award lecture: The saga of congenital muscular dystrophy, Neuropediatrics, 30, 55, 10.1055/s-2007-973461 Michelson, 1955, Dystrophia muscularis: a hereditary primary myopathy in the house mouse, Proc Acad Natl Sci USA, 41, 1079, 10.1073/pnas.41.12.1079 Xu, 1994, Defective muscle basement membrane and lack of M-laminin in the dy/dy mouse, Proc Natl Acad Sci USA, 91, 5572, 10.1073/pnas.91.12.5572 Xu, 1994, Murine muscular dystrophy caused by a mutation in the laminin alpha 2 (Lama2) gene, Nat Genet, 8, 297, 10.1038/ng1194-297 Miyagoe, 1997, Laminin alpha2 chain-null mutant mice by targeted disruption of the Lam2 gene: a new model of merosin (laminin 2)-deficient congenital muscular dystrophy, FEBS Lett, 415, 33, 10.1016/S0014-5793(97)01007-7 Kuang, 1998, Merosin-deficient congenital muscular dystrophy. Partial genetic correction in two mouse models, J Clin Invest, 102, 844, 10.1172/JCI3705 Moll, 2001, An agrin minigene rescues dystrophic symptoms in a mouse model for congenital muscular dystrophy, Nature, 413, 302, 10.1038/35095054 Hynes, 1992, Integrins: versatility, modulation, and signaling in cell adhesion, Cell, 69, 11, 10.1016/0092-8674(92)90115-S Burkin, 1999, The α7β1 integrin in muscle development and disease, Cell Tiss Res, 296, 183, 10.1007/s004410051279 Mayer, 1997, Absence of integrin α7 causes a novel form of muscular dystrophy, Nat Genet, 17, 318, 10.1038/ng1197-318 Hodges, 1997, Altered expression of the α7β1 integrin in human and murine muscular dystrophies, J Cell Sci, 110, 2873, 10.1242/jcs.110.22.2873 Cohn, 1999, Secondary reduction of alpha7B integrin in laminin α2 deficient congenital muscular dystrophy supports an additional transmembrane link in skeletal muscle, J Neurol Sci, 163, 140, 10.1016/S0022-510X(99)00012-X Burkin, 2001, Enhanced expression of the alpha 7 beta 1 integrin reduces muscular dystrophy and restores viability in dystrophic mice, J Cell Biol, 152, 1207, 10.1083/jcb.152.6.1207 Taverna, 1998, Dystrophic muscle in mice chimeric for expression of α5 integrin, J Cell Biol, 143, 849, 10.1083/jcb.143.3.849 Crosbie, 1999, Membrane targeting and stabilization of sarcospan is mediated by the sarcoglycan subcomplex, J Cell Biol, 145, 153, 10.1083/jcb.145.1.153 Barresi, 1997, Concomitant deficiency of β- and γ-sarcoglycans in 20 α-sarcoglycan (adhalin)-deficient patients: immunohistochemical analysis and clinical aspects, Acta Neuropathol, 94, 28, 10.1007/s004010050668 Crosbie, 2000, Molecular and genetic characterization of sarcospan: insights into sarcoglycan–sarcospan domains, Hum Mol Genet, 13, 2019, 10.1093/hmg/9.13.2019 Lebakken, 2000, Sarcospan-deficient mice maintain normal muscle function, Mol Cell Biol, 20, 1669, 10.1128/MCB.20.5.1669-1677.2000 Straub, 1999, ε-sarcoglycan replaces α-sarcoglycan in smooth muscle to form a unique dystrophin-glycoprotein complex, J Biol Chem, 274, 27989, 10.1074/jbc.274.39.27989 Barresi, 2000, Expression of γ-sarcoglycan in smooth muscle and its interaction with the smooth muscle sarcoglycan-sarcospan complex, J Biol Chem, 275, 38554, 10.1074/jbc.M007799200 Hack, 1998, γ-sarcoglycan deficiency leads to muscle membrane defects and apoptosis independent of dystrophin, J Cell Biol, 142, 1279, 10.1083/jcb.142.5.1279 Coral-Vasquez, 1999, Disruption of the sarcoglycan-sarcospan complex in vascular smooth muscle: a novel mechanism for cardiomyopathy and muscular dystrophy, Cell, 98, 465, 10.1016/S0092-8674(00)81975-3 Araishi, 1999, Loss of the sarcoglycan complex and sarcospan leads to muscular dystrophy in beta-sarcoglycan deficient mice, Hum Mol Genet, 8, 1589, 10.1093/hmg/8.9.1589 Liu, 1999, Sarcoglycan isoforms in skeletal muscle, J Biol Chem, 272, 38171, 10.1074/jbc.274.53.38171 Durbeej, 2000, Disruption of the β-sarcoglycan gene reveals pathogenetic complexity of limb-girdle muscular dystrophy type 2E, Mol Cell, 5, 141, 10.1016/S1097-2765(00)80410-4 Cohn, 2001, Prevention of cardiomyopathy in mouse models lacking the smooth muscle sarcoglycan-sarcospan complex, J Clin Invest, 107, R1, 10.1172/JCI11642 Betto, 1999, Ecto-ATPase activity of α-sarcoglycan (adhalin), J Biol Chem, 274, 7907, 10.1074/jbc.274.12.7907 Hack, 1999, Muscle degeneration without mechanical injury in sarcoglycan deficiency, Proc Natl Acad Sci USA, 96, 10723, 10.1073/pnas.96.19.10723 Allamand, 2000, Early adenovirus-mediated gene transfer effectively prevents muscular dystrophy in alpha-sarcoglycan deficient mice, Gene Therapy, 7, 1385, 10.1038/sj.gt.3301247 Cordier, 2000, Rescue of skeletal muscles of γ-sarcoglycan-deficient mice with adeno-associated virus-mediated gene transfer, Mol Therapy, 1, 119, 10.1006/mthe.1999.0019 Sullivan, 1999, Loss of A-type lamin expression compromises nuclear envelope integrity leading to muscular dystrophy, J Cell Biol, 147, 913, 10.1083/jcb.147.5.913 Richard, 2000, Loss of calpain 3 proteolytic activity leads to muscular dystrophy and to apoptosis-associated IκBα/nuclear factor κB pathway perturbation in mice, J Cell Biol, 151, 1583, 10.1083/jcb.151.7.1583 Bittner, 1999, Dysferlin deletion in SJL mice (SJL-Dysf) defines a natural model for limb girdle muscular dystrophy 2B, Nat Genet, 23, 141, 10.1038/13770 Frosk, 2002, Limb-girdle muscular dystrophy type 2H associated with mutation in TRIM32, a putative E3-ubiquitin-ligase gene, Am J Hum Genet, 70, 663, 10.1086/339083 Brockington, 2001, Mutations in the fukutin-related protein identify limb-girdle muscular dystrophy 2I as a milder allelic variant of congenital muscular dystrophy MDC1C, Hum Mol Genet, 10, 2851, 10.1093/hmg/10.25.2851 Camacho Vanegas, 2001, Ullrich scleroatonic muscular dystrophy is caused by recessive mutations in collagen typeVI, Proc Natl Acad Sci USA, 98, 7516, 10.1073/pnas.121027598 Cormand, 2001, Clinical and genetic distinction between Walker-Warburg syndrome and muscle-eye-brain disease, Neurology, 56, 1059, 10.1212/WNL.56.8.1059 Moghadaszadeh, 2001, Mutations in SEPN1 cause congenital muscular dystrophy with spinal rigidity and restrictive respiratory syndrome, Nat Genet, 29, 17, 10.1038/ng713 Bonaldo, 1998, Collagen VI deficiency induces early onset myopathy in the mouse: an animal model for Bethlem myopathy, Hum Mol Genet, 7, 2135, 10.1093/hmg/7.13.2135 Eklund, 2001, Lack of type XV collagen causes a skeletal myopathy and cardiovascular defects in mice, Proc Natl Acad Sci USA, 98, 1194, 10.1073/pnas.031444798 Andra, 1997, Targeted inactivation of plectin reveals essential function in maintaining the integrity of skin, muscle, and heart cytoarchitecture, Genes Dev, 11, 3143, 10.1101/gad.11.23.3143 Sarkar, 2000, Heterozygous loss of Six5 in mice is sufficient to cause ocular cataracts, Nat Genet, 25, 110, 10.1038/75500 Klesert, 2000, Mice deficient in Six5 develop cataracts: implications for myotonic dystrophy, Nat Genet, 25, 105, 10.1038/75490